History

1991 to 2004

Founded in 1991
Focus on supply to private sector export markets in developing countries
Established a reputation for excellence and reliability of supply with NGOs and major UN aid agencies
First UK Marketing Authorisation (2005): Metformin Tablets

Picture: The Morningside Team at their stand, during an International Exhibition.

2005 to 2012

Established a sales & marketing, Quality Assurance and regulatory presence in the UK
First third party contract supply order (2006)
Focus on niche, high-value molecules
50+ Marketing Authorisations secured
Growing infrastructure with the addition of three distribution centres
Building an international and UK distribution network

Picture: Morningside customers during an event in Guyana, South America.

2012 to 2016

Morningside wins the Queen’s Award for Innovation: International Trade 2012
The Morningside companies establish a Research & Development capability.
- The first product launched with full IP ownership (Sodium Fluoride Toothpaste: 2015)
Completed substantial marketing investment to launch the Headline Brand range
Development of supply to NHS hospitals, driving high growth and consistent supply
Further investment in infrastructure and new GMP approved buildings

Picture: Morningside’s Distribution Centre, in Loughborough, United Kingdom.

2016 to Today

Prime Minister Theresa May hails Morningside as ‘the best of British’ during a trade mission to India (2016)
Morningside wins the Innovation in Generics Award at the Pharmacy Business Awards (2017)
The Leicester Arena is renamed the Morningside Arena, as part of a major naming-rights deal (2018)
Focus on key therapeutic areas
Over 242 generic and branded licensed medicines in the UK and EU
Significant opportunity to expand into new global markets
Board of Trade Award received from former Secretary of State for International Trade, Dr Liam Fox (2018)
Our Chief Executive, Dr Nik Kotecha OBE, was named Entrepreneur of the Year at the 2019 Lloyds Bank National Business Awards and the national Innovation Entrepreneur of the Year at the 2019 Great British Entrepreneur Awards
In 2020, as part of the business’ continued expansion, a 5th office and warehousing unit was officially opened at our Loughborough site
In 2020 Morningside Pharmaceuticals gained Full Authorised Economic Operator (AEO F) status from HMRC
In 2021 our now Chairman, Dr Nik Kotecha OBE DL, was named a Regional EY Entrepreneur of the Year, as well as one of LDC’s 50 Most Ambitious Business Leaders. In the same year Dr Kotecha also made Medicine Maker magazine’s international Power List.

About this site